Market Place
Sourcing Support
Relay Therapeutic to Participate in Upcoming Investor Conferences
07 Nov 2024 //
GLOBENEWSWIRE
Relay Therapeutics Reports Q3 2024 Financials & Highlights
06 Nov 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Announce Q3 2024 Financial Results on Nov 6
30 Oct 2024 //
GLOBENEWSWIRE
Relay sheds 10% of staff after earlier layoffs in July
03 Oct 2024 //
FIERCE BIOTECH
Relay Therapeutics Announces Pricing Of Public Offering
10 Sep 2024 //
GLOBENEWSWIRE
Relay Therapeutics` Combo Cuts Breast Cancer Progression In Early Study
10 Sep 2024 //
REUTERS
Relay Therapeutics Announces Positive Data For RLY-2608
09 Sep 2024 //
GLOBENEWSWIRE
Relay Therapeutics Announces Proposed Public Offering of Stock
09 Sep 2024 //
GLOBENEWSWIRE
Relay Therapeutics Announces Webcast For RLY-2608 Data Report
06 Sep 2024 //
GLOBENEWSWIRE
Relay loses interest in SHP2 inhibitor after Genentech abandons collab
07 Aug 2024 //
FIERCE BIOTECH
Relay Therapeutics Reports Q2 2024 Results And Corporate Highlights
06 Aug 2024 //
GLOBENEWSWIRE
Relay Therapeutics To Announce Q2 2024 Results On August 6
30 Jul 2024 //
GLOBENEWSWIRE
Genentech sinks SHP2 pact, leaving Relay to race thinning field
17 Jul 2024 //
FIERCE BIOTECH
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
06 Jun 2024 //
GLOBENEWSWIRE
Relay, Pfizer: Combo Trial Of Atirmociclib With RLY-2608
05 Jun 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Upcoming Investor Conferences
21 May 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
13 May 2024 //
GLOBENEWSWIRE
Relay Therapeutics Q1 2024 Results, Corporate Highlights
02 May 2024 //
GLOBENEWSWIRE
Relay Therapeutics Q1 2024 Results on May 2
25 Apr 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Upcoming Investor Conferences
11 Apr 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
26 Feb 2024 //
GLOBENEWSWIRE
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
Relay to Announce Fourth Quarter and Full Year 2023 Financial Results
15 Feb 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in 6th Annual Biotechnology Conference
01 Feb 2024 //
GLOBENEWSWIRE
Relay Therapeutics Announces $30 Million Private Placement Financing
08 Jan 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference
07 Nov 2023 //
GLOBENEWSWIRE
Relay Reports Third Quarter 2023 Financial Results and Corporate Highlights
02 Nov 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Announce Third Quarter 2023 Financial Results
26 Oct 2023 //
GLOBENEWSWIRE
IRA drives Relay to pause plans to win approval in rare cancer
13 Oct 2023 //
FIERCE BIOTECH
Relay Therapeutics Announces RLY-4008 Data Showing Durable Responses Across Multiple FGFR2-Altered Solid Tumors
12 Oct 2023 //
GLOBENEWSWIRE
Relay to Present Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors
18 Sep 2023 //
GLOBENEWSWIRE
Relay Therapeutics Reports Second Quarter 2023 Financial Results
08 Aug 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Announce Second Quarter 2023 Financial Results
01 Aug 2023 //
GLOBENEWSWIRE
Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008
25 May 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
24 May 2023 //
GLOBENEWSWIRE
Relay Therapeutics Reports 1Q FYR 2023 and Corporate Highlights
04 May 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Announce 1Q 2023 FYR and Corporate Highlights
27 Apr 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
19 Apr 2023 //
GLOBENEWSWIRE
Relay Announces Initial Clinical Data Demonstrating that RLY-2608
18 Apr 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR
06 Mar 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
01 Mar 2023 //
GLOBENEWSWIRE
Relay Reports Fourth Quarter and Full Year 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Announce Fourth Quarter & Full Year 2022 Financial Results
16 Feb 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day
02 Feb 2023 //
GLOBENEWSWIRE
Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 //
GLOBENEWSWIRE
Relay Therapeutics Reports 3Q FYR and Corporate Highlights
03 Nov 2022 //
GLOBENEWSWIRE
Relay Therapeutics to Announce Third Quarter 2022 Financial Results
27 Oct 2022 //
GLOBENEWSWIRE
Relay kicks off public offering, seeking $300M after laying out robust ESMO data
12 Sep 2022 //
ENPTS
Foundation Medicine & Relay Collaborate to Develop FoundationOne CDx
12 Sep 2022 //
BUSINESSWIRE
Relay Therapeutics Announces Proposed Public Offering of Common Stock
12 Sep 2022 //
GLOBENEWSWIRE
Relay Therapeutics Announces Pricing of Public Offering of Common Stock
12 Sep 2022 //
GLOBENEWSWIRE
Relay spotlights expanded FGFR2 data
11 Sep 2022 //
FIERCEBIOTECH
Late Breaking Data Presented at ESMO 2022 Demonstrate Potential of RLY-4008
11 Sep 2022 //
GLOBENEWSWIRE
Relay Therapeutics Shares Surge
08 Sep 2022 //
NASDAQ
Relay Therapeutics drug shows promise in early trial
08 Sep 2022 //
STATNEWS
Relay Therapeutics to Present Clinical Data on RLY-4008 at ESMO Congress
18 Aug 2022 //
GLOBENEWSWIRE
Relay Therapeutics Reports Second Quarter 2022 Financial Results
04 Aug 2022 //
GLOBENEWSWIRE
Relay Therapeutics to Announce Second Quarter 2022 Financial Results
28 Jul 2022 //
GLOBENEWSWIRE
Relay builds case for anti-FGFR drug, shooting for first accelerated approval
27 Jun 2022 //
ENDPTS
